Otiprio (Otonomy, Inc.)


Welcome to the PulseAid listing for the Otiprio drug offered from Otonomy, Inc.. This Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Otonomy, Inc.
NON-PROPRIETARY NAME: ciprofloxacin
SUBSTANCE NAME: CIPROFLOXACIN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Quinolone Antimicrobial [EPC],Quinolones [Chemical/Ingredient]
ROUTE: INTRATYMPANIC
DOSAGE FORM: SUSPENSION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-02-11
END MARKETING DATE: 0000-00-00


Otiprio HUMAN PRESCRIPTION DRUG Details:

Item DescriptionOtiprio from Otonomy, Inc.
LABELER NAME: Otonomy, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 6(mg/mL)
START MARKETING DATE: 2016-02-11
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69251-201_07aed8f3-a904-4a0e-a20d-b5d5e9e07d97
PRODUCT NDC: 69251-201
APPLICATION NUMBER: NDA207986

Other CIPROFLOXACIN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Bayer HealthCare Pharmaceuticals Inc.Cipro
Blenheim Pharmacal, Inc.Ciprofloxacin
Bryant Ranch PrepackCiprofloxacin
Cardinal HealthCIPROFLOXACIN
Claris Lifesciences Inc.Ciprofloxacin
Hospira, Inc.CIPROFLOXACIN
Otonomy, Inc.Otiprio
Pfizer Labs, Division of Pfizer IncCiprofloxacin
Rebel Distributors CorpCiprofloxacin
RedPharm Drug Inc.Ciprofloxacin
Sagent PharmaceuticalsCiprofloxacin
Sandoz IncCiprofloxacin
STAT RX USA LLCCIPROFLOXACIN
Testpak Holding CompanyCiprofloxacin